Transcranial Direct Current Stimulation as an Adjuvant to an Intensive Comprehensive Aphasia Program in Chronic Stroke

S, Shamapant; S, Wortman-Jutt; E, Boutin; S, Bennet; C, Oromendia; L, Gerber; TP, Marquardt; DJ, Edwards
Abstract:
Background and Purpose: In this proof-of-concept pilot study, transcranial direct current stimulation (tDCS) was used as an adjuvant to speech therapy in an intensive comprehensive aphasia program (ICAP). Methods: Using a double-blind, sham controlled, between-group design, 1 mA of direct current was delivered via NEO-24 PiStim gel electrodes using a Starstim tDCS device.The anode was placed over the inferior frontal gyrus (FC5), with the cathode placed over the supra-orbital frontal area (AF8) of the contralesional side during the first 20 minutes of daily intensive speech therapy for a period of 15 consecutive weekdays, commencing on day-1 of an 8-week ICAP. Pre- and post-treatment standardized assessments and discourse analysis, as well as bi-weekly trained and untrained probes, were used as outcome measures. Results: Six subjects were analyzed; three received ICAP-tDCS and three received ICAP-sham. Five subjects were male. Ages ranged from 50 to 67 years. Time post-stroke at enrollment ranged from 8 months to 5.2 years. Subjects receiving ICAP-tDCS treatment demonstrated significantly higher improvement than ICAP-sham patients on the Boston Naming Test ( p=0.05), trained and untrained probes (p=0.05, untrained absolute increase p=0.05, percent increase p=0.38), and picture-description discourse (absolute increase p=0.05, percent increase p=0.38). There was no difference in the improvement of Western Aphasia Battery-AQ between ICAP-tDCS and ICAP-sham patients (absolute and percent increases both p=0.28). No adverse effects of tDCS or intensive behavioral training were reported. Following completion of the initial 3 weeks of adjunctive tDCS and tDCS-sham treatment, all subjects continued participation in the ICAP therapy with behavioral intervention only, and concluded the 8-week program. Conclusions: In this proof-of-concept pilot rehabilitation study, we demonstrate significant language improvements in chronic post-stroke aphasia, following intensive speech therapy combined with tDCS. Results should be confirmed in a larger randomized clinical trial.
Patologie/Applicazioni:
Anno:
2018
Tipo di pubblicazione:
Articolo
Parola chiave:
afasia; stimolazione elettrica transcranica; Stroke
Testata scientifica:
Stroke
Nota:
Studio pilota effettuato per verificare l'effetto della stimolazione elettrica transcranica applicata su pazienti con afasia post-stroke. L'esperimento, eseguito in doppio cieco con controllo sham, ha previsto il trattamento tDCS (15 sessioni giornaliere) con lo Starstim ed elettrodi PiStim posizionati sull'emisfero controlaterale alla lesione. I risultati mostrano significativi miglioramenti nel linguaggio, dovuti alla combinazione della terapia per l'afasia (ICAP - intensive comprehensive aphasia terapy) con la tDCS.
Hits: 2176

La nostra storia

GEA soluzioni si affaccia nel 2013 al mercato della strumentazione medicale di alto livello tecnologico ma la sua storia parte da più lontano, clicca qui per approfondire.  

GEA SOLUZIONI SRL
via Spalato 72/A, Torino
Tel.: 011 5821948 / 011 4463853
Fax: 011 0433281
Email: info @ geasoluzioni.it

P. IVA IT11696920013
REA TO1233648

EU-Cookies

Copyright © 2024 GEA SOLUZIONI SRL. Tutti i diritti riservati.

Search